The efficacy of monitoring neuromuscular blockade during surgery based on visual assessment of the response to calf stimulation was determined in twenty-five patients. The calf stimulator was adjusted before the administration of any muscle relaxant to produce a brisk ankle jerk. Following an initial bolus dose of atracurium (0.5 mglkg),further incremental doses (0.2 mglkg) were administered when the response to calf stimulation was small and obvious. The resultant neuromuscular blockade was judged to be adequate throughout the surgical procedures, with an average of five incremental doses of atracurium being administered. In the presence of neuromuscular blockade the response to calf muscle stimulation was often greater than that produced by supramaximal stimulation of the ulnar nerve with a peripheral nerve stimulator. The response to calf muscle stimulation often persisted after that resulting from ulnar nerve stimulation was abolished. The technique has only limited accuracy in assessing neuromuscular blockade. However, it may be useful in helping to avoid the wide fluctuations in blockade which are prone to occur with the intermediate duration competitive neuromuscular blocking agents.
The rapid recovery rates of the new competitive neuromuscular blocking agents, atracurium and vecuronium, tend to cause wide fluctuations in the level of neuromuscular blockade unless the patient is carefully monitored and incremental doses given promptly. 1.2 However, peripheral nerve stimulators specifically designed for monitoring neuromuscular blockade are not widely used in Australia. As an alternative some anaesthetists have used the change in response to calf muscle stimulation as an indication of the level of neuromuscular blockade. This study was undertaken to determine the requirements, limitations and overall efficacy of calf muscle stimulation as a monitor neuromuscular blockade during the adminstration of atracurium. PATIENTS AND METHODS Twenty-five adult surgical patients, ASA class 1-11, who gave informed consent were studied. They had a mean age of 45 years (range 22-77 years) and a mean weight of 77 kilograms (range 45-98 kilograms). Following induction of anaesthesia, the ulnar nerve was supramaximally stimulated at the wrist through cutaneous electrodes with a peripheral nerve stimulator. The nerve stimulator delivered a pulse of 0.2 msec duration at a rate of 0.1 Hz. The evoked twitch response of adductor pollicis in the immobilised arm was measured with a Grass FT -10 force-displacement transducer. Calf stimulators were applied to the medial aspect of the calf, with the output adjusted to produce a brisk ankle jerk. The calf muscle stimulator was a constant-voltage generator with a maximum output of 300 volts which delivered a square wave of 1 msec duration at a rate of 0.1 Hz.
The responsible anaesthetist (one of five different anaesthetists) maintained the neuromuscular blockade during surgery according to the protocol outlined in Table 1 and was not aware of the response recorded from the arm. A bolus dose ofatracurium (0.5 mg/kg) was administered to facilitate intubation after stabilisation of the control twitch response in the arm and adjustment of the calf stimulator output. The magnitude of the ankle jerk in response to calf stimulation was assessed visually and graded according to a scoring system from 0 to 4. If a prominent response (a calf stimulator score of 2 or greater) persisted after the admi.nistration of the initial bolus dose of atracunum, the calf stimulator output was readjusted to produce a just-detectable response. An incremental dose of atracurium (0.2 mg/kg) was subsequently administered whenever there was a small but obvious response to calf muscle stimulation (calf stimulator score of 2). Where clinic~lly possible, neuromuscular blockade f?llowmg the last incremental dose of atracunum was allowed to spontaneously recover. In these patients the response from the calf stimulator was observed during recovery and a separate observer noted the neuromuscular blockade in the upper limb whenever the calf stimulator score changed. When clinically indicated, the residual neuromuscular blockade was antagonised with neostigmine and atropine, Table 1 ).
RESULTS
The neuromuscular blockade was judged by the surgeons to be adequate th~oughout .the surgical procedures in the 25 patIents studIed. The mean duration of the procedures was 188 (SD 87) minutes with an average of. five incremental doses of atracunum administered (range 1-13).
The calf stimulator output was readjusted in five patients following an obvious response persisting after the administration of. the initial dose of atracurium. In these patIents profound degrees of neuromuscular blockade were maintained throughout the procedures. Incremental doses of atracurium were administered when the degree of neuromuscular blockade was such that there was 97% (SD 2) depression of control twitch height (range 95-100%).
Less profound degrees of blockade were maintained in the other twenty patients. For this group an incremental dose of atracurium was administered when the neuromuscular blockade produced 89% (SD 5) depression of the control twitch height (range 76-97%). The mean interval before the administration of the incremental doses for all patients was 27 (SD 4) minutes (range 19-43 minutes). The variation in the interval between the incremental doses of atracurium and the degree of neuromuscular blockade at the time of their administration was small for each patient. Neuromuscular function was allowed to spontaneously recover in twelve patients, and the mean recovery time (time from the injection of the last incremental dose to 95% recovery of control twitch height) was 42 minutes (range 36-52 minutes). In Table 2 is given the degree of neuromuscular blockade (twitch height expressed as a percentage of control) and the calf stimulator score as assessed during spontaneous recovery in these patients. The residual neuromuscular block was antagonised with neostigmine and atropine in thirteen patients. The mean recovery time was 5.5 minutes (range 2-12 minutes) after the administration of the reversal agents.
DISCUSSION
Calf stimulators cause contraction of the underlying muscle either by direct muscle stimulation or via depolarisation of the intramuscular nerve twigs. They theoretically may be able to monitor neuromuscular blockade, as muscle contraction occurs mostly as a result of neuromuscular transmission following depolarisation of the intramuscular nerve twigs at low stimulus currents. Intramuscular nerve twigs have a substantially lower electrical threshold than muscle fibres. 3 Calf stimulators must satisfy important requirements and limitations if they are to be used to monitor neuromuscular blockade. Foremost of these is the need to establish a control response before the administration of any muscle relaxant. The response to calf muscle stimulation depends upon many factors including the stimulator output, electrode type and position, skin resistance and muscle mass. These factors must be standardised before the response can be related to the degree of neuromuscular blockade.
The results of this study suggest that under appropriate conditions there is a correlation between the degree of neuromuscular blockade and the response to calf stimulation. The difficulty in visually quantifying large responses 4 makes the technique particularly inaccurate in assessing the recovery from neuromuscular blockade and limits its usefulness to assessing clinical levels of muscle relaxation. At these levels of blockade the Anaesthesia and Intensive Care, Vo!. 15. No. 4. November. 1987 response to calf stimulation was often larger than that observed from stimulation of the ulnar nerve with a peripheral nerve stimulator. This is due to the different characteristics of the stimulators, mode of stimulation, and stimulated muscle.
A peripheral nerve stimulator causes the nerve to depolarise once on stimulation by delivering a monophasic rectangular wave with a pulse width of 0.2-0.3 msec. 5 Calf stimulators are designed to produce the maximum mechanical response and deliver a longer, and with some devices biphasic, impulse to cause repetitive nerve firing. This increases the acetylcholine output and causes a greater response in the presence of neuromuscular blockade. The calf stimulator may also deliver sufficient current to cause considerable direct muscle stimulation. This should be easily recognised as it causes a persisting obvious response in the presence of a profound neuromuscular block. This occurred in the five patients in this group in whom the calf stimulator output was readjusted.
Another pomt to consider in comparing the response to ulnar nerve stimulation with that to calf stimulation is that the muscles being stimulated have different sensitivities to neuromuscular blocking agents. The adductor pollicis is predominantly a fast muscle and more sensitive to neuromuscular blocking agents than the muscles of the calf which are a combination of fast and slow muscles. 6 These differences in response explain the shortcomings of the technique of monitoring neuromuscular blockade using calf stimulation. The clinical usefulness of the technique is not great and its use may result in prolonged blockade or inadequate reversal of the residual neuromuscular blockade when long-acting competitive neuromuscular blocking agents are administered. 7 . 8 The rapid spontaneous recovery of the intermediate agents ensures that even profound degrees of block are reversible after only a short delay. 1. 2 In summary, calf stimulators may be clinically useful in helping to avoid the wide fluctuations in neuromuscular blockade which are prone to occur with the intermediate-duration competitive neuromuscular blocking agents. I They should not be considered as an alternative to a peripheral nerve stimulator when accurate monitoring is required.
